Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 3996.00 | 4286.50 | 0.9322 | 0.9131 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 2500.00 | 1434.95 | 4537.00 | 4286.50 | 1.0584 | 1.0733 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 4709.00 | 4286.50 | 1.0986 | 1.1227 |
| BT-20 | Lapatinib | 1 | uM | 9 | 2500.00 | 1434.95 | 4245.00 | 4286.50 | 0.9903 | 0.9877 |
| BT-20 | Linsitinib | 10 | uM | 9 | 2500.00 | 1434.95 | 3725.00 | 4286.50 | 0.8690 | 0.8298 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3207.00 | 4286.50 | 0.7482 | 0.6643 |
| BT-20 | Erlotinib | 10 | uM | 9 | 2500.00 | 1434.95 | 3006.00 | 4286.50 | 0.7013 | 0.5974 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 4310.00 | 4286.50 | 1.0055 | 1.0069 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 4504.00 | 4286.50 | 1.0507 | 1.0637 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 2500.00 | 1434.95 | 3177.00 | 4286.50 | 0.7412 | 0.6544 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3417.00 | 4286.50 | 0.7972 | 0.7325 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 2500.00 | 1434.95 | 4445.00 | 4286.50 | 1.0370 | 1.0465 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4158.00 | 4286.50 | 0.9700 | 0.9618 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 2500.00 | 1434.95 | 3982.00 | 4286.50 | 0.9290 | 0.9088 |
| BT-20 | Linsitinib | 1 | uM | 9 | 2500.00 | 1434.95 | 4035.00 | 4286.50 | 0.9413 | 0.9249 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3780.00 | 4286.50 | 0.8818 | 0.8469 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3832.00 | 4286.50 | 0.8940 | 0.8629 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 2597.00 | 4286.50 | 0.6059 | 0.4561 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3894.00 | 4286.50 | 0.9084 | 0.8820 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 4369.00 | 4286.50 | 1.0192 | 1.0243 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 4713.00 | 4286.50 | 1.0995 | 1.1238 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 4429.00 | 4286.50 | 1.0332 | 1.0419 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 4569.00 | 4286.50 | 1.0659 | 1.0825 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4580.00 | 4286.50 | 1.0685 | 1.0857 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 2500.00 | 1434.95 | 4356.00 | 4286.50 | 1.0162 | 1.0205 |